These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 8388271)
1. 1 alpha-Hydroxyvitamin D3 in the treatment of primary myelofibrosis: in vitro effect of vitamin D3 metabolites on the bone marrow fibroblasts. Hyodo H; Kimura A; Nakata Y; Ohta H; Kuramoto A Int J Hematol; 1993 Apr; 57(2):131-7. PubMed ID: 8388271 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the inhibitions of proliferation of normal and psoriatic fibroblasts by 1 alpha,25-dihydroxyvitamin D3 and synthetic analogues of vitamin D3 with an oxygen atom in their side chain. Morimoto S; Imanaka S; Koh E; Shiraishi T; Nabata T; Kitano S; Miyashita Y; Nishii Y; Ogihara T Biochem Int; 1989 Nov; 19(5):1143-9. PubMed ID: 2561444 [TBL] [Abstract][Full Text] [Related]
3. Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3. Hodler B; Evêquoz V; Trechsel U; Fleisch H; Stadler B Immunobiology; 1985 Nov; 170(4):256-69. PubMed ID: 3002965 [TBL] [Abstract][Full Text] [Related]
4. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Barreto AM; Schwartz GG; Woodruff R; Cramer SD Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664 [TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
6. 1 alpha(OH)D3 treatment and procollagen III (PC III) studies in idiopathic myelofibrosis. Tsatalas C; Curtoglou G; Fotopoulos D; Halkia P; Vyzantiadis AT; Sinakos Z Haematologica; 1989; 74(6):559-62. PubMed ID: 2628238 [TBL] [Abstract][Full Text] [Related]
7. In vitro effect of 1,25-dihydroxyvitamin D3 on proliferation and collagen synthesis by bone marrow fibroblasts. Wang JC Acta Haematol; 1992; 88(1):27-31. PubMed ID: 1414158 [TBL] [Abstract][Full Text] [Related]
8. Maturation-dependent regulation of protein kinase C activity by vitamin D3 metabolites in chondrocyte cultures. Sylvia VL; Schwartz Z; Schuman L; Morgan RT; Mackey S; Gomez R; Boyan BD J Cell Physiol; 1993 Nov; 157(2):271-8. PubMed ID: 8227160 [TBL] [Abstract][Full Text] [Related]
10. 1,25-Dihydroxyvitamin D3 inhibits myelopoiesis but not B-lymphopoiesis in long-term bone marrow cultures. Dorshkind K; Reichel H; Norman AW Exp Hematol; 1989 Jun; 17(5):436-42. PubMed ID: 2785458 [TBL] [Abstract][Full Text] [Related]
11. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
12. 1 alpha,25-dihydroxyvitamin D3 modulation in lipid metabolism in established bone marrow-derived stromal cells, MC3T3-G2/PA6. Shionome M; Shinki T; Takahashi N; Hasegawa K; Suda T J Cell Biochem; 1992 Apr; 48(4):424-30. PubMed ID: 1577879 [TBL] [Abstract][Full Text] [Related]
13. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. Campbell MJ; Reddy GS; Koeffler HP J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197 [TBL] [Abstract][Full Text] [Related]
14. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
15. Effect of 25-hydroxyvitamin D3 on vitamin D metabolites in primary biliary cirrhosis. Kaplan MM; Goldberg MJ; Matloff DS; Neer RM; Goodman DB Gastroenterology; 1981 Oct; 81(4):681-5. PubMed ID: 6973499 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of myelodysplastic syndrome and acute myelogenous leukemia with vitamin D3 [1 alpha(OH)D3]]. Irino S; Taoka T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1183-90. PubMed ID: 2837981 [TBL] [Abstract][Full Text] [Related]
17. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. Birkenhäger-Frenkel DH; Pols HA; Zeelenberg J; Eijgelsheim JJ; Schot R; Nigg AL; Weimar W; Mulder PG; Birkenhäger JC J Bone Miner Res; 1995 Feb; 10(2):197-204. PubMed ID: 7754799 [TBL] [Abstract][Full Text] [Related]
18. 1,25-dihydroxyvitamin D3-mediated transforming growth factor-beta release is impaired in cultured osteoblasts from patients with multiple pituitary hormone deficiencies. Sterck JG; Klein-Nulend J; Burger EH; Lips P J Bone Miner Res; 1996 Mar; 11(3):367-76. PubMed ID: 8852947 [TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin D metabolites on the expression of alkaline phosphatase activity by epiphyseal hypertrophic chondrocytes in primary cell culture. Hale LV; Kemick ML; Wuthier RE J Bone Miner Res; 1986 Dec; 1(6):489-95. PubMed ID: 3509742 [TBL] [Abstract][Full Text] [Related]
20. 1 Alpha-hydroxyvitamin D2 and 1 alpha-hydroxyvitamin D3 have anabolic effects on cortical bone, but induce intracortical remodeling at toxic doses in ovariectomized rats. Weber K; Kaschig C; Erben RG Bone; 2004 Sep; 35(3):704-10. PubMed ID: 15336607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]